United Therapeutics Stock Forecast - Naive Prediction
| UTH Stock | EUR 338.80 9.10 2.62% |
The Naive Prediction forecasted value of United Therapeutics on the next trading day is expected to be 346.39 with a mean absolute deviation of 8.33 and the sum of the absolute errors of 508.41. United Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of United Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
United |
United Therapeutics Naive Prediction Price Forecast For the 8th of January
Given 90 days horizon, the Naive Prediction forecasted value of United Therapeutics on the next trading day is expected to be 346.39 with a mean absolute deviation of 8.33, mean absolute percentage error of 116.19, and the sum of the absolute errors of 508.41.Please note that although there have been many attempts to predict United Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that United Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
United Therapeutics Stock Forecast Pattern
| Backtest United Therapeutics | United Therapeutics Price Prediction | Buy or Sell Advice |
United Therapeutics Forecasted Value
In the context of forecasting United Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. United Therapeutics' downside and upside margins for the forecasting period are 344.07 and 348.71, respectively. We have considered United Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of United Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent United Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 122.8657 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 8.3347 |
| MAPE | Mean absolute percentage error | 0.024 |
| SAE | Sum of the absolute errors | 508.4144 |
Predictive Modules for United Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as United Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for United Therapeutics
For every potential investor in United, whether a beginner or expert, United Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. United Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in United. Basic forecasting techniques help filter out the noise by identifying United Therapeutics' price trends.United Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with United Therapeutics stock to make a market-neutral strategy. Peer analysis of United Therapeutics could also be used in its relative valuation, which is a method of valuing United Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
United Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of United Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of United Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
United Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how United Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading United Therapeutics shares will generate the highest return on investment. By undertsting and applying United Therapeutics stock market strength indicators, traders can identify United Therapeutics entry and exit signals to maximize returns.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.97 | |||
| Day Median Price | 338.8 | |||
| Day Typical Price | 338.8 | |||
| Price Action Indicator | (4.55) | |||
| Period Momentum Indicator | (9.10) |
United Therapeutics Risk Indicators
The analysis of United Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in United Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting united stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.44 | |||
| Semi Deviation | 2.24 | |||
| Standard Deviation | 2.21 | |||
| Variance | 4.9 | |||
| Downside Variance | 5.9 | |||
| Semi Variance | 5.0 | |||
| Expected Short fall | (1.61) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin | |
| ADA | Cardano | |
| XRP | XRP |
Additional Information and Resources on Investing in United Stock
When determining whether United Therapeutics is a strong investment it is important to analyze United Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact United Therapeutics' future performance. For an informed investment choice regarding United Stock, refer to the following important reports:Check out Historical Fundamental Analysis of United Therapeutics to cross-verify your projections. For more detail on how to invest in United Stock please use our How to Invest in United Therapeutics guide.You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.